Literature DB >> 7729894

Cellular immune response to Mycobacterium leprae infection in human immunodeficiency virus-infected individuals.

E P Sampaio1, J R Caneshi, J A Nery, N C Duppre, G M Pereira, L M Vieira, A L Moreira, G Kaplan, E N Sarno.   

Abstract

The immune responses to Mycobacterium leprae and other mycobacterial antigens were studied in 11 leprosy patients with concurrent human immunodeficiency virus type 1 (HIV-1) infection. Three patients manifested borderline lepromatous leprosy, and eight patients had borderline tuberculoid (BT) leprosy. Despite the low CD4+ T-cell count in the peripheral blood, no histologic or phenotypic change in the cellular infiltrate in either the lepromatous or tuberculoid lesions was observed when compared with HIV-1-negative patients. Lepromatous lesions contained heavily parasitized macrophages and few CD8+ T cells. Lesions from the patients with BT leprosy showed extensive CD4+ T-cell infiltration despite a significant reduction in CD4+ T-cell counts in the peripheral blood. No acid-fast bacilli were detected in the tuberculoid lesions. HIV-1 infection did not alter the lack of response in lepromatous leprosy to M. leprae antigens either in vitro or in vivo. In contrast, the skin test response to M. leprae antigens as well as the in vitro lymphoproliferative responses to mycobacterial antigens that are usually seen in patients with tuberculoid leprosy were abrogated in the BT HIV-1+ patients. However, production of gamma interferon in response to the same stimuli was preserved in most of the patients. Analysis of cytokine gene expression showed activation of additional cytokine genes in the unstimulated peripheral blood cells of patients with both leprosy and HIV-1 infections as compared with cells from patients with leprosy alone. These results suggest that granuloma formation in leprosy can be independent of the impaired CD4+ T-cell response of the HIV-1 infection. Furthermore, in HIV-1+ individuals with M. leprae infection, activation of cytokine genes is observed even when the circulating CD4+ T-cell count is significantly reduced.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729894      PMCID: PMC173234          DOI: 10.1128/iai.63.5.1848-1854.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

Review 1.  Mycobacterium avium complex infection in the acquired immunodeficiency syndrome.

Authors:  C R Horsburgh
Journal:  N Engl J Med       Date:  1991-05-09       Impact factor: 91.245

2.  Leprosy as cause of false-positive results in serological assays for the detection of antibodies to HIV-1.

Authors:  V L Andrade; J C Avelleira; A Marques; F R Vianna; M Schechter
Journal:  Int J Lepr Other Mycobact Dis       Date:  1991-03

3.  Is HIV infection a risk factor for leprosy?

Authors:  J M Pönnighaus; L J Mwanjasi; P E Fine; M A Shaw; A C Turner; S M Oxborrow; S B Lucas; P A Jenkins; J A Sterne; L Bliss
Journal:  Int J Lepr Other Mycobact Dis       Date:  1991-06

4.  Leprosy and human immunodeficiency virus infection. A closer look at the lesions.

Authors:  C Kennedy; R A Lien; E Stolz; T van Joost; B Naafs
Journal:  Int J Dermatol       Date:  1990-03       Impact factor: 2.736

5.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

6.  Cutaneous response to recombinant interleukin 2 in human immunodeficiency virus 1-seropositive individuals.

Authors:  M J McElrath; G Kaplan; R A Burkhardt; Z A Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

7.  Effect of multiple interferon gamma injections on the disposal of Mycobacterium leprae.

Authors:  G Kaplan; N K Mathur; C K Job; I Nath; Z A Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

8.  Lymphocyte transformation test in leprosy; correlation of the response with inflammation of lesions.

Authors:  G Bjune; R S Barnetson; D S Ridley; G Kronvall
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

9.  The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes.

Authors:  W C Van Voorhis; G Kaplan; E N Sarno; M A Horwitz; R M Steinman; W R Levis; N Nogueira; L S Hair; C R Gattass; B A Arrick; Z A Cohn
Journal:  N Engl J Med       Date:  1982-12-23       Impact factor: 91.245

10.  Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients.

Authors:  E P Sampaio; A L Moreira; E N Sarno; A M Malta; G Kaplan
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Mycobacterium leprae-host-cell interactions and genetic determinants in leprosy: an overview.

Authors:  Roberta Olmo Pinheiro; Jorgenilce de Souza Salles; Euzenir Nunes Sarno; Elizabeth Pereira Sampaio
Journal:  Future Microbiol       Date:  2011-02       Impact factor: 3.165

2.  Lower numbers of natural killer T cells in HIV-1 and Mycobacterium leprae co-infected patients.

Authors:  Karina I Carvalho; Fernanda R Bruno; Jennifer E Snyder-Cappione; Solange M Maeda; Jane Tomimori; Marilia B Xavier; Patrick A Haslett; Douglas F Nixon; Esper G Kallas
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

3.  Two patients coinfected with Mycobacterium leprae and human immunodeficiency virus type 1 and naive for antiretroviral therapy who exhibited type 1 leprosy reactions mimicking the immune reconstitution inflammatory syndrome.

Authors:  M A B Trindade; N Y S Valente; M I P Manini; M D F Takahashi; C F D Anjos; G Benard; B Naafs
Journal:  J Clin Microbiol       Date:  2006-10-04       Impact factor: 5.948

4.  Hansen's disease and HIV coinfection with facial nerve palsy.

Authors:  Nidhi Yadav; Sumit Kar; Bhushan Madke; Nitin Gangane
Journal:  J Neurosci Rural Pract       Date:  2015 Apr-Jun

Review 5.  The continuing challenges of leprosy.

Authors:  D M Scollard; L B Adams; T P Gillis; J L Krahenbuhl; R W Truman; D L Williams
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

6.  HIV-M. leprae interaction: can HAART modify the course of leprosy?

Authors:  Euzenir Nunes Sarno; Ximena Illarramendi; José A Costa Nery; Anna M Sales; Maria C Gutierrez-Galhardo; Maria L Fernandes Penna; Elizabeth Pereira Sampaio; Gilla Kaplan
Journal:  Public Health Rep       Date:  2008 Mar-Apr       Impact factor: 2.792

7.  Immune cellular parameters of leprosy and human immunodeficiency virus-1 co-infected subjects.

Authors:  Karina I Carvalho; Solange Maeda; Luciana Marti; Jane Yamashita; Patrick A J Haslett; Esper G Kallas
Journal:  Immunology       Date:  2008-02-12       Impact factor: 7.397

8.  Evaluation of cellular phenotypes implicated in immunopathogenesis and monitoring immune reconstitution inflammatory syndrome in HIV/leprosy cases.

Authors:  Carmem Beatriz Wagner Giacoia-Gripp; Anna Maria Sales; José Augusto da Costa Nery; Joanna Reis Santos-Oliveira; Ariane Leite de Oliveira; Euzenir Nunes Sarno; Mariza Gonçalves Morgado
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

9.  Interactions between leprosy and human immunodeficiency virus: More questions than answers.

Authors:  Kingsley Nnanna Ukwaja
Journal:  J Neurosci Rural Pract       Date:  2015 Apr-Jun

10.  Leprosy: an overview of pathophysiology.

Authors:  Ramesh Marne Bhat; Chaitra Prakash
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.